Circus SE's Rollout Delay Erases Two-Thirds of Market Value — and Raises Hard Questions for August Shareholders

Circus SE cuts 2026 revenue guidance to €5.2M from €44-55M, EBITDA loss widens, shares down 67.5% in a month; analysts slash targets.

The arithmetic of Circus SE's current predicament is brutal. A company that guided toward €44–55 million in revenue for 2026 now expects just €5.2 million — roughly a tenth of its original ambition. The market has responded accordingly: shares have shed 67.54 percent over the past month, and the equity is now valued at €43.58 million, a figure that once seemed like a rounding error on the growth story this German food-robotics firm was telling.

The trigger was an ad-hoc disclosure on July 16, in which management conceded that the bulk of system deliveries earmarked for the second half of 2026 would slip into 2027. That single scheduling shift upended the company's entire financial framework. The EBITDA outlook deteriorated just as sharply: instead of a loss between €6 million and €8 million, Circus now anticipates a shortfall of roughly €17 million for the year. The revised revenue figure, management noted, is based on firm customer orders already on the books.

The sell-off has been unrelenting. Over the past seven trading days, the stock has fallen 12.50 percent, with yesterday's session alone accounting for a 5.29 percent drop to €1.54. With annualized volatility running at 158.05 percent, this remains a name for the risk-tolerant only.

Analysts slash targets, but conviction varies

The guidance cut triggered an immediate wave of recalibration across the sell-side. Montega AG moved its rating down from Buy to Hold on July 20, slashing its price target from €10.00 to €2.20 in one stroke. Baader took a similarly aggressive knife to its numbers on the day of the announcement itself, cutting its target from €19.00 to €3.00 — though it notably held its Buy recommendation. mwb research went further on the target front, trimming from €46.00 to €8.40, while maintaining its speculative Buy rating.

The divergence in those targets — ranging from €2.20 to €8.40 — underscores just how wide the uncertainty band has become. Analysts are effectively acknowledging that the old growth narrative, which justified a triple-digit valuation, no longer holds water.

Insider buying offers a counter-signal

Not everyone is running for the exits. Dr. Jan-Christian Heins, a member of the company's leadership circle, acquired 5,004 shares on July 17 at an average price of €2.15 — a transaction worth roughly €10,758. The purchase came the day after the profit warning, a timing that suggests either conviction in the turnaround or a willingness to back the story with personal capital at a moment of maximum doubt.

Battlefield deployment and Gulf expansion

Amid the financial turbulence, Circus continues to make operational headway in niche markets. The company has begun live operations with its catering robots in the Kyiv region, working alongside the 3rd Assault Brigade of Ukraine's ground forces — a first entry into the Ukrainian market that carries both strategic and symbolic weight. Separately, the commercial rollout has commenced in Abu Dhabi following regulatory approvals in the United Arab Emirates.

The company also closed the acquisition of Belgian food-robotics firm Alberts in early July, a deal financed through shares subject to a 26-month lock-up period. That transaction brings compact systems for automated soup and pasta preparation into the Circus portfolio, broadening its product range beyond its core offerings.

New leadership, new questions

The C-suite has been reshuffled in response to the crisis. Christian Bauer, whose résumé includes stints at Volocopter and Daimler, has taken over as CFO and co-CEO, tasked with overhauling capital planning and M&A strategy. The previous CFO, Fabian Becker, moves to the supervisory board of Circus Defence SE after roughly five years in his executive role, while former co-CEO Claus Holst Gydesen assumes the chairmanship of the advisory board.

Whether this management shake-up can restore credibility is another matter. The next test comes on August 20, when shareholders gather for the annual general meeting. With the rollout pushed into 2027 and a newly formed leadership team needing to explain how it will bridge the gap, the agenda is unlikely to be comfortable. The market will be listening closely for specifics on how the delayed deliveries translate into a credible 2027 outlook — and whether the company's cash position can sustain the wait.